News

GATEWAY IS NOW ACTIVELY ENROLLING AT 3 US CLINICAL SITES!

#GATEWAY is a Vivet Therapeutics clinical trial for #WilsonDisease, taking place at several clinical sites across the United States and Europe.

Learn more about this currently recruiting clinical trial and our #Gene Therapy, VTX-801:

www.gatewaytrialwilsondisease.com

February 2022 Update

By Published On: March 10, 2022Categories: Clinical Trials

Share This Story, Choose Your Platform!